Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2000

View Archived Issues

Mixed Y1 antagonist/Y4 agonist 1229U91 examined in rats and Y1 knockout mice

Drug screening technology company emerges from NeuroSearch

Selective 5-HT7 receptor antagonist SB-269970-A characterized

Flibanserin reduces anxiety without locomotor effects in rat model

GPC Biotech and Karo Bio to develop novel antibiotics

Novo Nordisk and AHP settle Activella patent dispute

Matrix submits second part of NDA for IntraDose

InterMune acquires additional rights to Actimmune

U.S. affiliates of Takeda establish strategic merger agreement

AmBisome approved in U.S. for cryptococcal meningitis in AIDS patients

British Biotech announces preliminary results for year ending in April 2000

Drug discovery collaboration between Pharmacia and Pharmacopeia restructured

Organon's fertility treatment now available in Germany

Abbott seeks E.U. approval for lopinavir as HIV therapy

Cell Pathways to market Nilandron to urologists

Immunex licenses prostate cancer-derived antigens from UroCor

Newly discovered inhibitor of pestivirus replication may lead to new treatments for HCV

Hepatoprotective effects of ZNC-2381 described in several experimental models

Combination of natural ingredients as a potential new treatment for prostatitis

OC144-093 characterized as a novel inhibitor of P-gp-mediated MDR in vitro and in vivo

R-848 potently modulates IgE synthesis in PBMCs from normal and allergic donors

Methylprednisolone derivative P-4114 effective against allergic bronchoconstriction in guinea pigs

FDA approves Sarafem for treatment of premenstrual dysphoric disorder

Novel guanylate cyclase activators designed at Aventis

Several newly issued patents cover related series of smooth muscle cell proliferation inhibitors

Lilly's new 5-HT-modulating compounds useful for CNS disorders

Antagonists of platelet adhesion receptor in development at Merck as antithrombotics

Xenoxins identified at Transgene as new agents for arrhythmias, CF and hormonal imbalance

New cationic lipids useful for nonviral gene delivery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...